Based on the WHO’s Anatomical Therapeutical Chemical (ATC) classification system, virtually all marketed therapeutics are covered here in 48 topical sections. Each section contains a general introduction to the therapeutic class, current developments, and challenges, followed by a systematic listing of all important marketed products. For each therapeutic, up-to-date information on compound structure, mechanism, formulation, clinical use, time on market, and production methods is provided, complete with refrences to the scientific and patent literature.
With ULLMANN’s being one of the most renowned and trusted references in the field of industrial chemistry, this selection of ULLMANN’s articles is an indispensable guide for every professional in the pharmaceutical and medical sector and provides reliable data on more than 3, 500 pharmaceutical products marketed up to 2021.
Inhoudsopgave
Stomatological Preparations (A01)
Drugs for Acid-Related Disorders (A02)
Drugs for Functional Gastrointestinal Disorders (A03)
Antiemetics and Antinauseants (A04)
Bile and Liver Therapy (A05)
Drugs for Constipation (A06)
Antidiarrheals, Intestinal Antiinflammatory and Antiinfective Agents (A07)
Anti-Obesity Drugs (A08)
Antidiabetic Drugs (A10)
Vitamins (A11)
Anabolic Agents for Systemic Use (A14)
Other Alimentary Tract and Metabolism Products (A16)
Antithrombotics and Antihemorrhagics (B01, B02)
Cardiovascular System (C)
Dermatologicals, 1. Introduction (D)
Dermatologicals, 2. Antifungals, Emollients and Protectives, and Antipruritics for Dermatological Use (D05, D06, D07)
Dermatologicals, 3. Antipsoriatics, Antibiotics and Chemotherapeutics, and Corticosteroids for Dermatological Use (D05, D06, D07)
Dermatologicals, 4. Antiseptics and Disinfectants, Anti-Acne Preparations, and Other Dermatological Preparations (D08, D10, D11)
Genitourinary System and Sex Hormones (G)
Hormone Therapeutcis – Systemic Hormonal Preparations, Excluding Reproductive Hormones and Insulins (H)
Antiinfectives for Systemic Use, 1. Antibacterials (J01)
Antiinfectives for Systemic Use, 2. Antimycotics (Antifungals) and Antimycobacterials (J02, J04)
Antiinfectives for Systemic Use, 3. Antivirals (J05)
Antineoplastic and Immunomodulating Agents (L01, L02)
Drugs for Musculo-Skeletal System (M)
Anesthetics (N01)
Analgesics (N02)
Antiepileptics (N03)
Anti-Parkinson Drugs (N04)
Antipsychotics (Neuroleptics, N05A)
Anxiolytics (N05B)
Hypnotics and Sedatives (N05C)
Antidepressants (N06A)
Psychostimulants (N06B)
Anti-Dementia Drugs (N06D)
Parasympathomimetics, Anti-Addiction Drugs, Anti-Vertigo Drugs, and Other Nervous System Drugs (N07)
Antiparasitics (PC)
Respiratory Disorders, 1. Introduction (R)
Respiratory Disorders, 2. Nasal Preparations and Decongestants for Topical Use (R01)
Respiratory Disorders, 3. Throat Preparations (R02)
Respiratory Disorders, 4. Inhalants for Obstructive Airway Diseases (R03)
Respiratory Disorders, 5. Oral Drugs for Obstructive Airway Diseases (R03)
Respiratory Disorders, 6. Cough and Cold Preparations (R05)
Respiratory Disorders, 7. Antihistamines for Systemic Use (R06)
Respiratory Disorders, 8. Respiratory Stimulants (R07)
Sensory Organs, 1. Ophthalmologicals (S01)
Sensory Organs, 2. Otologicals (S02)
All Other Therapeutic Products and Contrast Media (V03, V08)
Over de auteur
Axel Kleemann, Ph D in Chemistry, is former Director of Degussa AG Organic Chemical Research, former Executive Director of ASTA Medica AG, and Professor at the University of Frankfurt (Germany), with more than 40 years experience in the corporate pharma sector.
Bernhard Kutscher, Ph D in Chemistry, is Professor at the Technical University Munich (Germany), with more than 35 years of professional experience as manager for various healthcare, pharma and chemical companies.
Meer e-boeken van dezelfde auteur (s) / Editor
28.262 E-boeken in deze categorie
